chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I flew out on Tuesday May 31. Connected flights once. Wednesday, I went to our first meeting and when I was there, they told us to go into a different room because they needed to disinfect the room because the day prior there were people in there who were positive for COVID. My hotel was also in a mall and there were thousands of kids in this mall. Lots of people during the trip and on the plane. When I got home on June 3, I had a headache so I said I should take a test just in case. I took an at home test that came back negative. Monday morning, I went to the office June 6, I had a tickle in my throat and ears felt full. I wore a mask at the office and worked that day and made an appointment for urgent care at 7pm. before this appointment, I did another at home test, and it was positive. Urgent care said if it was positive there was no need to be there. I still had ear pressure and a sore throat. Tuesday morning, I woke up with a fever, muscle aches, muscle cramping. My fever was at 102.1. I called my NPs office and did a telehealth visit. He decided to give me Paxlovid and to get that filled. I'm on my second day of that. My fever broke because my clothes were soaked and had Charlie horses in both legs. Ears feel full, throat hurts, but nothing too bad right now.
2nd day-nausea, arm site pain which subsided. day 5-7 -severe itching around injection site. swelling and erythema as well
it's like they're going to get hoarsness; arm was sore; been feeling nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), DYSPHONIA (it's like they're going to get hoarsness) and NAUSEA (been feeling nauseous) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included Catheterization arterial (catheterization done on the right arm) on 19-Mar-2021. Concurrent medical conditions included Hypertension and GERD. Concomitant products included FAMOTIDINE for GERD, CLOPIDOGREL for an unknown indication.    On 11-Mar-2021 at 4:40 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced NAUSEA (been feeling nauseous). On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 13-Mar-2021, the patient experienced DYSPHONIA (it's like they're going to get hoarsness). At the time of the report, PAIN IN EXTREMITY (arm was sore) had resolved and DYSPHONIA (it's like they're going to get hoarsness) and NAUSEA (been feeling nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's concomitant medications included unspecified blood thinners, high blood pressure medication and supplements.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-044215 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-044215:cross linked
This spontaneous report was received from a certified medical assistant (CMA). It was reported that 15 improperly stored doses of VAQTA (dose, route, lot# not reported) had been administered to 15 patients on unspecified dates. No adverse effects were reported. No PQC was involved. This is one of several reports received from the same source. Additional information has been requested.
prolonged febrile seizure x 24 hrs post vax; pt also vomited & had diarrhea 24 hrs p/sz;
Extreme arm soreness and pain that radiates down entire left arm and slightly into the back, inability to move arm. Tingling through the neck occurred the day of administration but dissipated afterward. Patient states she is unable to move her arm to even take her shirt off when changing.
Pt put age as 12 but he is 19 days away from turning 12. Pt received 0.3ml pfizer vaccine as the first dose.
Patient called stating yesterday she experienced "what felt like the flu".  States that she felt awful, stayed in bed all day, fever--felt like she was burning up then got the chills, sweat through all of her clothes and hair.  Today she's at work but she feels weak, unable to really think clearly.  I asked her what was her temperature, she didn't take it but knows how she feels when she has a fever.  Also, she recevied the Td back on 2/8/2000 and said she didn't have this same reaction to that vaccine.
day 5 post vaccine: edema in axillary lymph node, fatigue. day 6 post vaccine: increased swelling in axillary lymph node. day 7 post vaccine: increased axillary lymph node described as "golf ball sized", erythema at site of vaccine. day 8 post vaccine: generalized malaise, intense erythema at vaccination site.  Increased lymph node involvement. day 9 post vaccine: pt. "felt bad", had fever. day 10 post vaccine: Fever 102, tightness in chest, swelling of right axillary region, pain in back of neck. Admitted to hospital for febrile illness and hydration. day 11 post vaccine: fever 102.6. day 12 post vaccine: released from hospital.
recvd 3 doses of Engerix-B; SEP92 anti-HBS was neg/nonresponder; pt works in SCU;
Extreme shoulder pain. Have been prescribed prednisone, HORIZANT and had a cortisone injection in back.
Paramedics/ nursing staff performed assessment. Medical staff ran vitals and motor function tests. Staff provide orange juice and water to patient post assessment.
Systemic: HOT IN THROAT AND NOSE -Medium, Additional Details: COMPLAINED OF THROAT BEING WARM AND NOSE BEING WARM. VITALS WERE STABLE AND EXAMINED BY CLINIC NP. DAUGHTER SAID AFTER LEAVING HE WAS COUGHING AND HAVING TROUBLE SPEAKING SO SHE TOOK TO THE ER AND THEY GAVE BENADRYL, STEROID(UNKNOWN) AND PRESCRIBED EPIPEN DOCTOR SAID REACTION WAS MODERATE. DOCTOR ADVISED NOT RECEIVING THE SECOND DOSE.
SIDS - 11/25/1998. MD reported pt had a displaced skull fracture
Caller experienced tingling and hot after 10 mins. Fainted shortly after and blood sugar was taken at vaccine site. Ambulance came by and saw that blood sugar was low. Took him to hospital. Had fainting spells every couple of days for 3 months. Eventually subsided but still experiencing lightheadedness every day and a very high heart rate. Sporadic stomach pain. Clammy, pale, inconsistent temperature. Episodes last an hour. Nausea. Complete 180 of his lifestyle prior to vaccine. Denies anxiety from issue.
pt fell asleep upon returning home fr getting shots @ clinic; about 3hr later devel hives on trunk, eyes began to swell; per phone instruction of family MD gave DPH & taken to ER; waited x 1 hr in ER;swelling began to dec;lt thigh swollen
Back Pain; This is a spontaneous report received from a contactable consumer. A 41-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in Deltoid Left on 21Jan2021 10:00 (Batch/Lot Number: EL8982) as SINGLE DOSE for covid-19 immunization.  Medical history included ongoing allergies from 2000. Concomitant medication(s) included montelukast sodium (SINGULAIR) taken for allergies from 2005 and ongoing; levocetirizine dihydrochloride (XYZAL) taken for allergies from 2009 and ongoing.  The patient experienced back pain on 22Jan2021. No treatment received. The outcome was recovered. Seriousness criteria from reporter was not serious.   No follow up attempts are needed no further information is expected.
Localized inflammatory reaction (R) deltoid 6cm x 4cm, warm and tender, occurred w/in 35 hrs of vaccine.
Mild "gurgling" in chest and wheezing when "jogging on Mar 24-27 and then again April 1 thru April 6 with discomfort. Has pacemaker which was decreased to rate 50 (resting) day before vaccine. Consulted cardiologist, had occup hltn and ER visits but no specific findings. Smallpox vaccine was given to pt on 3/18/03. Pt has had a pacemaker for > 5 years. On 3/17 (the day before the vaccine was given) she had an appt with her cardiologist and had cardiac ECHO and other tests and all was reported to her as okay. Pacemaker resting rate was decreased from 60 to 50. On the 7th day after the vaccine, 3/24, she expereinced a mild gurgling sound in her chest and throat upon awakening, and some wheezing and chest tightness when jogging. Those symptoms continued for three days. She also had fatigue and a weight gain of a few pounds but with no change in eating habits. On 3/27, she reported the symptoms to the vaccine site monitor nurse who, upon consultation with the health physician, advised pt to see her cardiologist and gave pt couples of the CDC info on smallpox and cardiac warning to present to her doctor. Pt phoned her Dr's office on March 28th but was not able to get an appt and her doctor's office advised ehr to go to urgent care if she got worse. Pt was seen on 4/1 by the registered nurse at her cardiologist's office. No action was taken and advice was to call in if symptoms increased. Pt reports that the nurse speculated that her symptoms may have been due to the vaccine and were not related to the decreased rate of her pacemaker. The symptoms did increase and she also experienced more chest "discomfort" so on 4/3 the health physician transported her to occupational health who were doing any smpox vacc follow-up. Occup health referred her to the ER and told pt they would fax the info there. Pt reports that the ER blood was drawn, a rectal eam was done, an EKG and chest x-ray were done. Several doctors saw her and each doctor asked her why she was there, and denied having seen the fax. Pt reports that she was discharged after several hours, was told that everything was okay but that she should call her cardiologist to get a "nuclear medicine stress test." No written referral or results were given to her. She was given a preprinted handout about chest pains. She reports that hse had night sweats on 4/3 through 4/6. The chest tightness and other symptoms went away and pt does not plan follow up unless she has severe symptoms. Pt has not had any chest pressure or wheezing since her 4/3 emergency room visit.
Seizure activity onset about 2/20. Baby felt warm but mother didn't assess temperature. Baby described as lethargic with HR 70 when EMT's arrive at home of patient. Medical records received on 3/21/2005 states a second seizure occurred on 3/10/2005, but was now on the left side. Pt was also fussy the evening of vaccinations and eczema was noted f/u PE of 3/12/05.
t104.8 ax; seen by MD 25JUN92 placed on treatment for ear infection; MD states ear infect alone did not cause temp contributes to DTP inject;
muscle tightness in my shoulder up to my neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history).    On 21-Jan-2021 at 11:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021 at 12:00 PM, the patient experienced MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck). At the time of the report, MUSCLE TIGHTNESS (muscle tightness in my shoulder up to my neck) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to cross link MOD21-11080 (Patient Link).
STAT RN called at covid vaccine clinic. Patient identified x 2. RN present, patient alert and oriented x 4. Patient got Covid pfizer vaccine and 15 minutes after patient felt dizzy and nauseous . Blood pressure 145/75 HR 103 stable O2 sat 96%. Patient remains alert and oriented x 4, responding well. Patient assisted in laying down. Dr  came and assessed patient. No further orders given. Continue to monitor patient. Patient complained of breathing feels tight with heavy pressure on chest. Dizziness resolving, nausea clear. Denies any headache. Assisted patient in standing up.Patient stated chest pressure got worse when standing up. Patient sat back and conversing appropriately. VS stable. Dr  came and  assessed pt. Advised pt to take her inhaler at home and rest.  Denies any dizziness nor nausea nor vomiting.  Denies any throat swelling.  Patient remains stable. Okay to send patient home. Pt left clinic in stable condition.
No adverse event; Dose administered after manufacturer date of expiry 12-Mar-2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry 12-Mar-2023) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 071B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Mar-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry 12-Mar-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry 12-Mar-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry 12-Mar-2023).    The concomitant medication was not reported by reporter. The vaccine was shipped frozen to the facility on 01-Mar-2023 and was initially stored in the refrigerator on the same day. The vial did not undergo any temperature excursions. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. The treatment medication was not reported by reporter.
No side effects reported; VARIVAX was administered after it experienced a supported temperature excursion.; This spontaneous report has been received from a health business professional (HBP) (administrator) referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not provided. Concomitant medication included diluent.  On 12-JUL-2023, the patient was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (0.5 ml; lot # W025277 has been verified to be valid, expiration date reported and established as 10-AUG-2024; strength and route were not reported) for prophylaxis, which underwent a supported temperature excursion of -8.6 degrees Celsius for a time frame of 51 minutes (product storage error). There was a previous temperature excursion of -11.5 degrees Celsius for 1 hour and 16 minutes. No side effects were reported. No further details were given. No additional adverse event (AE) or product quality complaint (PQC) was reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2307USA007068: US-009507513-2307USA006778: US-009507513-2307USA006784: US-009507513-2307USA007708: US-009507513-2307USA006760: US-009507513-2307USA006854: US-009507513-2307USA006846: US-009507513-2307USA006990:
I woke up the morning after the 2nd dose of the vaccine unable to walk due to extreme pain on the soles of my feet. This continued and progressed for 6 weeks, unable to walk. Over the next few months, the burning pain then began to spread up his legs then to my hands, and up my arms. These symptoms are still occurring today though I am able to walk enough and push through the pain. I continue to gain symptoms each month. Additional symptoms that I have gained over the past year include carpal tunnel, burning of the ears, back of neck shoulders feet, and hands, rash on thighs, stiffness of all joints of the hand, brain fog, intolerance to physical activity or hot or cold tempuratures, intolerance to alcohol, burning and tingling of the extremities, and red sensitive skin. An EMG confirmed generalized peripheral neuropathy and ruled out Guillain-Barre Syndrome. Doctors have not been able to confirm any other diagnoses nor have they provided any potential treatments.
COVID arm-  The patient had COVID arm 8 days after receiving her first shot. She had swelling and itching of the arm that resolved after 1 day
Varicella - Information has been received from a physician concerning a 5 year old white female patient who on 31 Jul 1997 was vaccianted sc with the first dose of varicella virus vaccine live (lot 522685/0419k) in the left arm.  Concomitant vaccinations included a first dose of measles (+) mumps (+) rubella virus vaccine live (MSD) lot 620805/0239E).  Subsequently, the patient developed a chicken pox rash with 30-25 lesions on torso, arms, and head.  The patient was afebrile and had no known exposure to wild type varicella,  The patient sought unspecified medial attention.
This spontaneous report as received from a physician via a company representative refers to two patients of unknown age and gender. On an unknown date the patients were vaccinated with ZOSTAVAX. On an unknown date the patients experienced shingles. The outcome of shingles is unknown. The patient were seen in the office. Treatment was not specified. Additional information has been requested.
rash (itchy); tingling sensation all over the body; rash (hard); rash (hot to touch); 3 inch rash in the injection site; pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash (itchy)), PARAESTHESIA (tingling sensation all over the body), VACCINATION SITE INDURATION (rash (hard)), VACCINATION SITE RASH (rash (hot to touch)) and VACCINATION SITE ERYTHEMA (3 inch rash in the injection site) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced RASH PRURITIC (rash (itchy)), PARAESTHESIA (tingling sensation all over the body), VACCINATION SITE INDURATION (rash (hard)), VACCINATION SITE RASH (rash (hot to touch)), VACCINATION SITE ERYTHEMA (3 inch rash in the injection site) and VACCINATION SITE PAIN (pain in the injection site). At the time of the report, RASH PRURITIC (rash (itchy)), PARAESTHESIA (tingling sensation all over the body), VACCINATION SITE INDURATION (rash (hard)), VACCINATION SITE RASH (rash (hot to touch)), VACCINATION SITE ERYTHEMA (3 inch rash in the injection site) and VACCINATION SITE PAIN (pain in the injection site) outcome was unknown.            No concomitant medication was reported.  No treatment details were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
pain in her arm; feel like wet rag; fever in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her arm), DISCOMFORT (feel like wet rag) and PYREXIA (fever in her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 30-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in her arm), DISCOMFORT (feel like wet rag) and PYREXIA (fever in her arm). At the time of the report, PAIN IN EXTREMITY (pain in her arm), DISCOMFORT (feel like wet rag) and PYREXIA (fever in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment were provided No concomitant were provided
4pm - Exhaustion 8pm - Headache 6am - Body fatigue, sore joints, nausea, headache, extreme arm soreness 12pm - Extreme Headache, Chills, extreme arm soreness 6pm - Fever, chills, vomiting, diarrhea, pounding headache, extreme arm soreness 4/9/2021 6am - Headache fainter, lethargic, extreme arm soreness  10am - Exhaustion 9pm - Extreme arm soreness 4/10/2021 General tiredness - Extreme arm soreness 4/11/2021 General fatigue - Arm tender 4/12/2021 General fatigue - Arm better but still tender
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 24-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-018243 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-018243:
Patient stated that she had chills after getting Moderna booster. Also had headache, body stiffness.
Monday night 12/05/2022, I had a sharp pain in my third toe in my right foot I treated it with ointment as I assumed it was dry skin and a deep crack. I woke Tuesday or the next day and my toe was black and blue on the skin near the nail. On Wednesday I saw a nurse practitioner to rule out an infection and she attributed the bruise to a trauma but I had no trauma.
The vaccine administered to the patient was an expired lot number, no adverse events occurred at the time of vaccination.
Patient was given vaccine at 17 when it is only approved for 18 and older.  He did not have an adverse reaction.
patient reports having pain, swelling at injection site, redness, and hot to the touch. Patient also reports having a fever of 104.2
10 hours post vaccination, patient developed febrile seizure as described by parents, temperature was 101F and had tonic episode with upward eye deviation that lasted about a minute
Body aches, weakness, heart racing, wheezing, headache, nausea, chills, hives on back, stomach, chest, neck, face, and arms.